Chronic Hepatitis B Virus Infection clinical trials

Explore recruiting chronic hepatitis b virus infection clinical trials.

Recruiting chronic hepatitis b virus infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Hepatitis B Virus Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Platform Study Evaluating the Efficacy and Safety of Investigational Therapies in Participants with Chronic Hepatitis B Infection (PREVAIL)

France, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Regimens Containing VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects with Chronic Hepatitis B Virus Infection

Romania, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Children and Adolescent Subjects with Chronic Hepatitis B Virus Infection

Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AB-101 Following Oral Administration in Healthy and Chronic Hepatitis B Subjects

Romania, Italy, Bulgaria

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Randomized, Double-Blind, Active-Controlled Multicenter Phase 2 Study Evaluating the Efficacy and Safety of ALG-000184 Compared with Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg-Negative Adult Subjects with Chronic Hepatitis B Virus Infection (B-SUPREME)

Spain, Italy, Bulgaria, Romania, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Blinded, Placebo-Controlled Dose-Ranging Phase 1b Study of the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects with Chronic Hepatitis B Virus Infection

Bulgaria, Romania

Human Pharmacology (Phase I)- Other EU CTIS Study details

Chronic Hepatitis B Virus Infection trials by city

Chronic Hepatitis B Virus Infection in Toronto Chronic Hepatitis B Virus Infection in Vancouver Chronic Hepatitis B Virus Infection in Montreal Chronic Hepatitis B Virus Infection in Calgary Chronic Hepatitis B Virus Infection in Edmonton Chronic Hepatitis B Virus Infection in Ottawa Chronic Hepatitis B Virus Infection in Winnipeg Chronic Hepatitis B Virus Infection in Quebec City Chronic Hepatitis B Virus Infection in Hamilton Chronic Hepatitis B Virus Infection in Kitchener Chronic Hepatitis B Virus Infection in London Chronic Hepatitis B Virus Infection in Halifax Chronic Hepatitis B Virus Infection in New York Chronic Hepatitis B Virus Infection in Los Angeles Chronic Hepatitis B Virus Infection in Chicago Chronic Hepatitis B Virus Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease